Real-time enrollment status for this cardiomyopathy clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 2:24 AM UTC
| NCT Number | NCT07052903 |
| Recruiting Status | Recruiting |
| Condition | Cardiomyopathy |
| Phase | PHASE3 |
| Target Enrollment | 1,250 participants |
| Active Locations | 39 sites in the US |
| Sponsor | Alnylam Pharmaceuticals |
| Last Updated on CT.gov | June 12, 2026 (Jun 12, 2026) |
As of July 18, 2026: Clinical trial NCT07052903 is currently recruiting participants. This phase3 study for cardiomyopathy is actively seeking new participants at 39 locations across the United States. The study is sponsored by Alnylam Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07052903 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 39 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07052903 was last updated Jun 12, 2026 (June 12, 2026). HelloStudys verifies this status automatically.